ASCP panel offers deprescribing guidance to curb psychiatric overprescribing, simplify polypharmacy, and improve outcomes with tapering and
Holly A. Swartz, MD
Advertisement
Dr Swartz is a professor of psychiatry and the director of the Center for Advanced Psychotherapy at the University of Pittsburgh School of Medicine.
Articles by Holly A. Swartz, MD
Expert psychiatrists share new ASCP deprescribing guidance, tackling overprescribing, primary-care challenges, and practical tapering strategies to improve safer, patient-centered mental health care.
Learn when CBT/IPT beats medications, when to combine antidepressants, and why patient preference drives depression recovery in 6–12 weeks in this podcast.
Explore the intersection of psychotherapy and pharmacology in treating mood disorders, emphasizing personalized approaches for optimal patient outcomes.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
New 6-Month Data From Second Phase 3 Trial Confirms Rapid Effect of COMP360 for TRD
2
Treating Cannabis Addiction and Withdrawal: Latest Clinical Data
3
Phase 2 Trial Initiated for Briumvi for Treatment-Resistant Schizophrenia
4
Take-Home Messages: Clinical Confidence in Transitioning Patients to Cobenfy
5